Related Experiment Video
Updated: Aug 16, 2026

Massive Pontine Hemorrhage by Dual Injection of Autologous Blood
Published on: May 29, 2021
The coagulopathy of massive transfusion
J-F Hardy1, P de Moerloose, C M Samama
1Département d'Anesthésiologie, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. jean-francois.hardy@umontreal.ca
Massive transfusion coagulopathy differs in trauma versus elective surgery. Trauma patients develop disseminated intravascular coagulation, while surgery patients show early fibrinogen decrease; treatment strategies must adapt to context and available blood products.
Area of Science:
- Anesthesiology
- Hematology
- Critical Care Medicine
Background:
- Massive transfusion can lead to coagulopathy in adult patients with prior normal hemostasis.
- Coagulopathy onset and severity vary significantly between trauma and elective surgery settings.
Purpose of the Study:
- To review the pathophysiology of coagulopathy in massively transfused patients.
- To highlight differences in coagulopathy between trauma and elective surgery.
- To discuss the impact of evolving blood products on management strategies.
Main Methods:
- Review of pathophysiology of coagulopathy in massively transfused patients.
- Analysis of differences in coagulopathy between trauma and elective surgery.
- Discussion on the evolution of blood products and their management implications.
Main Results:
- Trauma patients: uncontrolled tissue trauma, shock, hypothermia, and disseminated intravascular coagulation are common; coagulopathy monitoring is often delayed.
- Elective surgery patients: controlled environment, initial fibrinogen decrease, late thrombocytopenia; monitoring is ongoing, and treatment is simpler.
- Blood product availability has shifted, impacting treatment recommendations (e.g., fresh-frozen plasma as first-line).
Conclusions:
- Coagulopathy in massive transfusion remains a significant clinical challenge.
- Treatment strategies require adaptation based on the specific clinical context (trauma vs. surgery) and available blood products.
- Limited evidence supports current treatment options, necessitating further research for improved management of massively transfused patients.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

